Can an antihistamine–steroid combo pill beat standard allergy meds?

NCT ID NCT06916884

First seen Jul 23, 2026 · Last updated Jul 24, 2026 · Updated 1 time

Summary

This phase 3 trial tests whether a once-daily pill combining desloratadine (an antihistamine) and betamethasone (a corticosteroid) relieves nasal allergy symptoms better than desloratadine alone. About 70 adults with moderate-to-severe allergic rhinitis will take either the combo or the single drug for 10 days. Researchers will compare changes in nasal symptom scores and track side effects to see if the combination offers a meaningful advantage.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a fixed-dose combination of desloratadine (an antihistamine) and betamethasone (a corticosteroid)
What this could lead to
If the combination works better than the antihistamine alone, it could offer a more effective daily pill for people with moderate-to-severe allergic rhinitis.
What could go wrong
This is a relatively small phase 3 trial (70 people), and adding a steroid may increase side effects without providing meaningful extra relief. Results may not apply to all allergy sufferers.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALLERGIC RHINITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Laboratorio Silanes, S.A. de C.V.

    Mexico City, 11000, Mexico

More trials for these conditions

Other studies related to the condition(s) this trial covers.